Some Big Pharma companies are stockpiling drugs in the U.K. in the event that Brexit rules for moving drugs smoothly from the EU to the U.K. have not been hammered out by the March deadline. But now, England’s National Health
read moreWith a new rival from Johnson & Johnson eyeing a market-share grab, Pfizer and Astellas need to pick up the pace on Xtandi’s bid for broader use. So the partners are moving up completion dates for two key trials in
read moreMore than two years after GlaxoSmithKline was forced to fight legal allegations that a generic version of Paxil was linked to a man’s suicide, the company has prevailed. But pharma continues to face failure-to-warn lawsuits over generic knockoffs, despite a
read moreAstraZeneca’s strategy for taking on GlaxoSmithKline in the respiratory department hasn’t been playing out as planned. Just witness the latest failure: Its COPD med Bevespi fell flat in a head-to-head test against GSK’s Anoro. More: AstraZeneca's Bevespi takes discouraging hit
read moreAuthorities in China are taking tough steps against Juxin Biotech and the companies that built its plant after a massive explosion killed 10 people. More: China prosecuting managers of Juxin Biotech after plant explosion kills 10 Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals